Skip to main content

Proteopure Bags $100K from PLSG for Protein Isolation Technology

NEW YORK, March 21 (GenomeWeb News) - Pittsburgh Life Sciences Greenhouse said today it has invested $100,000 in Proteopure, a spinout of Carnegie Mellon University.

 

Proteopure is developing 2DE preparation kits using spin columns to bind and isolate proteins. It is expected to be commercially available this year.

 

PLSG is a public/private partnership founded by the University of Pittsburgh, Carnegie Mellon, UPMC Health System, and the Commonwealth of Pennsylvania.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.